Flu News and Research

RSS

Jamieson releases flu-fighting formula with echinacea

Jamieson Laboratories, Canada's largest manufacturer of advanced natural-health products, announced the release of FluShield™, a clinically proven flu-fighting formula that is made with a patented, next-generation echinacea extract known as LPx3.

27 Oct 2010

Long non-protein coding RNAs respond to SARS virus infection, says study

For the first time, scientists have discovered that a poorly understood class of RNA produced in a mammal's cells during a respiratory virus attack may affect the outcome of the infection. Their findings are reported today in mBio, a journal of the American Society for Microbiology.

27 Oct 2010

Mundus studies potential for VTOL UAV against Malaria

Mundus Group Inc., studies potential for VTOL UAV to provide increased capabilities in fight against Malaria and disease spread through mosquitoes with precision aerial laser eradication treatments.

26 Oct 2010

Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV

Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.

26 Oct 2010

H1N1 linked to increased rate of empyema in children

The H1N1 influenza pandemic has led to a sharp increase in the number of children with a serious "secondary" bacterial infection called empyema in children, suggests a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

25 Oct 2010

New synthetic population can help computational modelers to study infectious diseases

To help computational modelers who study the spread of infectious diseases, including flu, researchers supported by the National Institutes of Health at RTI International in North Carolina created a synthetic population mirroring U.S. demographics. Now they've added another layer of realism: where the virtual citizens live.

25 Oct 2010

Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) as one of the five manufacturers to supply seasonal influenza vaccine to the citizens of Beijing.

25 Oct 2010

State Watch: N.Y. approves rate hikes; Arizona referendum on health insurance mandate; Md. insurer cuts broker fees

The Sacramento Bee: "A Sacramento federal judge has ordered the state to keep providing adult dental, podiatric and chiropractic services to poor people in underserved rural areas until it gets permission from federal health authorities to discontinue the benefits. U.S. District Judge Frank C. Damrell Jr. ruled Wednesday that, while the services are not mandatory under the federal Medicaid program (Medi-Cal in California), the Legislature's decision to end them last year as a cost-saving measure was unlawful without federal approval.

25 Oct 2010

New research shows flu virus with D222G mutation can cause pneumonia

A variant of last year's pandemic influenza linked to fatal cases carried a mutation that enabled it to infect a different subset of cells lining the airway, according to new research. The study, due to be published next week in the Journal of Virology, suggests that the mutant virus could have impaired the lungs' ability to clear out germs.

25 Oct 2010

New multi-centre trial to treat cold and flu in children

Three Canadian research teams are trying to determine if a novel Canadian medicine approved by Health Canada for adults can help parents deal with the hacking coughs and runny noses their children suffer.

22 Oct 2010

Researchers analyze drugs' efficiency on influenza A virus

Beating the flu has always been tough, but it has gotten even more difficult in recent years. Two of the four antiviral drugs used to treat a nasty case of the influenza A virus no longer work.

22 Oct 2010

Union Springs, BIOSAFE enter agreement to commercialize HM4100 products

Kentucky-based Union Springs Pharmaceuticals announced today an agreement with BIOSAFE® of Pittsburgh to market products containing the patented and novel antimicrobial polymer, HM4100. Similar to its flagship product, MyClyns (antimicrobial germ spray), Union Springs Pharmaceuticals will identify the products as MyClyns Antimicrobial Surface Treatments and will be the first company to bring these unique products to the market.

22 Oct 2010

Study: Flu vaccine is money loser for doctors paid by Medicaid

More poor children would get the flu vaccine if Medicaid increased the reimbursement to doctors for giving the shot, according to a new study published in the journal Pediatrics.

21 Oct 2010

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis.The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

19 Oct 2010

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Having an egg allergy is not a reason to avoid getting the 2010-2011 flu vaccination.

19 Oct 2010

Higher Medicaid reimbursement rates could increase childhood vaccinations

Reuters: A new study in the journal Pediatrics suggests that raising Medicaid reimbursement rates could help more children from low-income families receive flu vaccinations. "Although the vaccine itself is provided free of charge to children covered by Medicaid, doctors are only reimbursed for about half the cost of administering it," and are losing money in the process, say researchers.

18 Oct 2010

Researchers to develop technologies that can mask horrid taste of children's medicines

A spoonful of sugar is the traditional way to help medicines 'go down'. But getting young children to take foul-tasting medicines - even if their lives depend on it - requires more than a bit of added sweetener. According to the World Health Organisation (WHO), each year over eight million children die of diseases that could be avoided if essential medicines were available in appropriate formulations for children.

18 Oct 2010

Study finds correlation between flu vaccination and Medicaid reimbursement rates

Increasing the amount that physicians are reimbursed by Medicaid for administering influenza shots may raise vaccination rates among poor children. That is the conclusion of a study published online today in the journal Pediatrics.

18 Oct 2010

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis. The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

18 Oct 2010

Silver studded bacteria could help treat common cold and flu

Finally scientists may have found a potential cure for common cold. They have found “silver bullets” in yogurt that could destroy viruses and provide a cure for the flu and common cold.

18 Oct 2010

Flu News and Research

Jamieson releases flu-fighting formula with echinacea

Long non-protein coding RNAs respond to SARS virus infection, says study

Mundus studies potential for VTOL UAV against Malaria

Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV

H1N1 linked to increased rate of empyema in children

New synthetic population can help computational modelers to study infectious diseases

Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

State Watch: N.Y. approves rate hikes; Arizona referendum on health insurance mandate; Md. insurer cuts broker fees

New research shows flu virus with D222G mutation can cause pneumonia

New multi-centre trial to treat cold and flu in children

Researchers analyze drugs' efficiency on influenza A virus

Union Springs, BIOSAFE enter agreement to commercialize HM4100 products

Study: Flu vaccine is money loser for doctors paid by Medicaid

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Higher Medicaid reimbursement rates could increase childhood vaccinations

Researchers to develop technologies that can mask horrid taste of children's medicines

Study finds correlation between flu vaccination and Medicaid reimbursement rates

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Silver studded bacteria could help treat common cold and flu

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News